{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:14Z","timestamp":1786118774446,"version":"build-2736575974"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A 76-year-old man managed for stage IV advanced melanoma was treated with nivolumab-ipilimumab, complicated by corticotropic insufficiency, hypothyroidism, and rash. At first evaluation,\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT clearly showed complete metabolic response allowing continued treatment with nivolumab alone. At 6\u2009months,\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT fully confirmed the persistence of complete metabolic response but showed the appearance of cutaneous focal uptakes of both lateral thighs and a cutaneous diffuse uptake on lower limbs. Clinically, he had a severe verrucous lichenoid eruption with eruptive keratoacanthomas, confirmed after resection. We report a case of rare immunotherapy-induced keratoacanthomas first showed by\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000005692","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T16:14:11Z","timestamp":1743696851000},"page":"e288-e289","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Rare Immuno-Induced Keratoacanthomas Showed on 18F-FDG PET\/CT in a Metastatic Melanoma Patient"],"prefix":"10.1097","volume":"50","author":[{"given":"Naia","family":"Oillarburu","sequence":"first","affiliation":[{"name":"Department of Oncodermatology, IUCT Oncopole, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Pages","sequence":"additional","affiliation":[{"name":"Department of Oncodermatology, IUCT Oncopole, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Sibaud","sequence":"additional","affiliation":[{"name":"Department of Oncodermatology, IUCT Oncopole, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lamant","sequence":"additional","affiliation":[{"name":"Department of Pathology, IUCT Oncopole, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Terroir","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, IUCT Oncopole, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"bib1-20250403","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40257-017-0336-3","article-title":"Dermatologic reactions to immune checkpoint inhibitors: skin toxicities and immunotherapy","volume":"19","author":"Sibaud","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"bib2-20250403","doi-asserted-by":"crossref","first-page":"1071983","DOI":"10.3389\/fimmu.2023.1071983","article-title":"Cutaneous manifestations associated with immune checkpoint inhibitors","volume":"14","author":"Watanabe","year":"2023","journal-title":"Front Immunol"},{"key":"bib3-20250403","doi-asserted-by":"crossref","first-page":"e15472","DOI":"10.1111\/dth.15472","article-title":"Multiple eruptive squamoproliferative lesions during anti-PD1 immunotherapy for metastatic melanoma: pathogenesis, immunohistochemical analysis and treatment","volume":"35","author":"Star","year":"2022","journal-title":"Dermatol Ther"},{"key":"bib4-20250403","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/CJI.0000000000000498","article-title":"Multiple eruptive keratoacanthomas secondary to nivolumab immunotherapy","volume":"47","author":"Olsen","year":"2024","journal-title":"J Immunother"},{"key":"bib5-20250403","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jaad.2015.11.033","article-title":"Keratoacanthoma (KA): an update and review","volume":"74","author":"Kwiek","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"bib6-20250403","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/bjd.20389","article-title":"A clinical and biological review of keratoacanthoma","volume":"185","author":"Tisack","year":"2021","journal-title":"Br J Dermatol"},{"key":"bib8-20250403","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejca.2022.03.008","article-title":"European consensus-based interdisciplinary guideline for melanoma. Part 1: diagnostics: update 2022","volume":"170","author":"Garbe","year":"2022","journal-title":"Eur J Cancer"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000005692","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:40:49Z","timestamp":1786034449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000005692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005692","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"2024-09-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}